Acute leukaemia can progress rapidly, usually requiring immediate treatment. The two most common types of acute leukaemia are acute myeloid leukaemia (AML), most often diagnosed in older people, and acute lymphoblastic leukaemia (ALL) most often diagnosed in younger people.
Both chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) are often picked up incidentally in primary care. This is because presentation of these diseases can be gradual, with most patients with CLL diagnosed after undergoing a routine blood test.
Our courses will support you to:
Increase your awareness of the symptoms and diagnosis of acute and chronic leukaemia
Understand the different presentations, referral and management of acute and chronic leukaemia
Confidently assess the need for urgent referrals in accordance with the NICE NG12 guidelines
Appropriately safety net patients
Increase your confidence in dealing with angry patients
Find out more:
Access GatewayC’s Acute Leukaemia – Early Diagnosis course here
Access GatewayC’s Chronic Leukaemia – Early Diagnosis course here
20th January 2022 Lots of women have never heard of human papillomavirus (HPV), for many the first time they hear about HPV is upon their diagnosis after receiving smear test results. A HPV diagnosis can often carry psychological symptoms such as fear, guilt, shame,...
19th January 2022 The Interim Clinical Commissioning Policy describes which patients are eligible for COVID treatments. In short and not exclusively, this includes people who have: An active solid or blood cancer Received radiotherapy in last 6 months Received any...
7th January 2021 It has been another successful year for GatewayC, despite the challenges of the current pandemic. GatewayC continues to deliver free, high-quality online cancer education. So far, we have supported over 10,000 healthcare professionals across England...
17th December 2021 As the year comes to an end, we have gathered our top 10 Cancer Keys and resources from 2021. How many COVID vaccines do people with cancer need? People who might have been immunosuppressed at the time of their first two vaccine doses are eligible...